Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - glimepiride - tafla - 1 mg

Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - glimepiride - tafla - 2 mg

Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - glimepiride - tafla - 3 mg

Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - glimepiride - tafla - 4 mg

Liên Minh Châu Âu - Tiếng Iceland - EMA (European Medicines Agency)

cheplapharm arzneimittel gmbh - lyfleysu, glimepiride - sykursýki, tegund 2 - lyf notuð við sykursýki - tandemact er ætlað fyrir sjúklinga með tegund-2 sykursýki sem sýna óþol að kvarta eða fyrir hvern kvarta er ekki ætlað og hver ert nú þegar meðhöndluð með sambland af lyfleysu og glimepiride.

Liên Minh Châu Âu - Tiếng Iceland - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - sykursýki, tegund 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 fyrir tiltæk gögn um mismunandi samsetningar).

Liên Minh Châu Âu - Tiếng Iceland - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - sykursýki, tegund 2 - lyf notuð við sykursýki - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 fyrir tiltæk gögn um mismunandi samsetningar).

Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz a/s* - sitagliptinum hýdróklóríð - filmuhúðuð tafla - 100 mg

Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz a/s* - sitagliptinum hýdróklóríð - filmuhúðuð tafla - 50 mg

Liên Minh Châu Âu - Tiếng Iceland - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - sykursýki, tegund 2 - lyf notuð við sykursýki - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.